Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
![](https://fprimecapital.com/wp-content/uploads/2019/01/alternate-healthcare-illustration-1024x1024.jpg)
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
Innovent Highlights Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous NSCLC
November 9, 2018 -
B3C Newswire
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations
November 8, 2018 -
PRNewswire
Maine’s Northern Light Beacon Health Partners with PatientPing to Coordinate Care for Patients Throughout the State — and Beyond
November 6, 2018 -
Globe Newswire
Unum Therapeutics to Present Preclinical Data on a New, Emerging Platform Technology for Solid Tumors at the SITC Annual Meeting
November 6, 2018 -
Business Wire
Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives
November 6, 2018 -
Business Wire
Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives
November 6, 2018 -
Business Wire
Compass Therapeutics Announces Preclinical Data on Lead Antibody Program and NK Cell Engager Platform to be Presented at the Society for Immunotherapy of Cancer Annual Meeting
November 6, 2018 -
B3C Newswire
Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option
November 5, 2018 -
Globe Newswire
Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases
November 1, 2018 -
PRNewswire
PatientPing Expands Care Coordination Offering to Help Organizations Succeed Under BPCI Advanced
November 1, 2018 -
Reuters
China’s Innovent Biologics Makes 5 Percent Gain in Hong Kong Debut
October 31, 2018 -
PRNewswire
Adagene Announces First Patient Dosed in United States and Acceptance of IND in China for ADG-106
October 31, 2018 -
Globe Newswire
Orchard Therapeutics Announces Pricing of Initial Public Offering
October 30, 2018 -
Innovent Biologics Raises $421 Million in Hong Kong IPO
October 25, 2018 -
Globe Newswire
Cytek Biosciences Debuts Advanced Flow Cytometry System that Breaks the Cost Barrier
October 23, 2018 -
Business Wire
Kyruus Announces Launch of ProviderMatch for Salesforce on the Salesforce AppExchange to Help Health Systems Deliver Optimal Access Experience
October 23, 2018 -
Gene therapy biotech Orchard Therapeutics sets terms for $200 million IPO
October 23, 2018 -
PRNewswire
US HealthVest is Developing a New Behavioral Hospital on Hendricks Regional Health Plainfield Campus
October 17, 2018 -
Devoted Health, New Medicare Advantage Business, Raises $300 Million
October 16, 2018 -
PRNewswire
TraceLink Announces Availability of End-to-End DSCSA Saleable Returns Verification Solution for Pharmaceutical Manufacturers and Wholesale Distributors
October 16, 2018 -
PRNewswire
PatientPing’s National Community of ACO Providers Generate More than $270 Million in Shared Savings
October 10, 2018 -
Business Wire
Buoy Health Named to CNBC’s 2018 Upstart 100 List Highlighting Innovation and Rapid Growth
October 9, 2018 -
PRNewswire
FAREVA Selects TraceLink to Comply with EU FMD Regulations
October 8, 2018 -
Orchard Therapeutics plans $172.5 million U.S. IPO
October 5, 2018 -
Business Wire
Buoy Health Receives Robert Wood Johnson Foundation Artificial Intelligence Award for Patient Health Education
October 3, 2018 -
TraceLink Surpasses 1,000 Customer Milestone, Including Over 500 Pharmaceutical Manufacturing Companies
October 3, 2018 -
Centogene, Denali Therapeutics Partner to Recruit Parkinson’s Patients for Drug Program
October 3, 2018 -
FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company
October 2, 2018 -
Notable Health Named an IDC Innovator for Enterprise Wearable Software Solutions in Health Care
October 1, 2018 -
Modis Therapeutics Announces $30M Series A Financing
October 1, 2018 -
Pharmeasy raises $50 million in Series C funding
September 29, 2018 -
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188
September 29, 2018 -
Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture
September 27, 2018 -
NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer
September 24, 2018 -
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Previously Treated Non-Small Cell Lung Cancer at Annual Meeting of the Chinese Society of Clinical Oncology
September 21, 2018 -
b-ONE Ortho Receives U.S. FDA 510(k) Clearance for Total Hip System
September 21, 2018 -
CareStack™ Announces Completion of $16 Million Financing to Expand Cloud-Based Enterprise Platform for Dental Practices
September 21, 2018 -
Devoted Health Receives License from State of Florida
September 20, 2018 -
Hua Medicine Successfully Completes Initial Public Offering and Listing on the Hong Kong Stock Exchange
September 14, 2018 -
Iora Health and Humana Expand Relationship to Provide More Humana Medicare Advantage Plan Members Access to Improved Care in Arizona, Georgia and Washington
September 13, 2018 -
Innovent doses first patient in Phase III sintilimab trial for NSCLC
September 13, 2018 -
Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing
September 12, 2018 -
Unum Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference
September 10, 2018 -
Innovent’s Anti-CD47 Antibody IBI188 Receives IND Approval in China
September 10, 2018 -
Notable Health Closes $13.5 Million Series A Financing to Expand Artificial Intelligence Powered Physician-Patient Interaction Platform
September 6, 2018 -
Tempest Therapeutics Names Dr. Ginna Laport CMO
September 5, 2018 -
Checkmate Pharmaceuticals Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate Combination Therapy with CMP-001 and Avelumab
September 5, 2018 -
Precision BioSciences Announces Collaboration with University of Pennsylvania to Develop Genome Editing Therapeutics
September 5, 2018 -
Turnstone Biologics and the La Jolla Institute for Allergy and Immunology Enter into Strategic Collaboration for Personalized Neoantigen Immunotherapies
September 4, 2018 -
Surface Oncology to Present at the Baird 2018 Global Healthcare Conference
September 4, 2018 -
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
August 29, 2018 -
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
August 29, 2018 -
Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources
August 29, 2018 -
TraceLink, which helps pharma companies trace drugs through the supply chain, just raised $93 million
August 23, 2018 -
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
August 13, 2018 -
Buoy Health Partners With Boston Children’s Hospital To Improve The Way Parents Currently Assess Their Children’s Symptoms Online
August 10, 2018 -
Protenus President to Discuss How Analytics Align Privacy and Security Vision to Reality
August 6, 2018 -
Denali Therapeutics Announces Positive Clinical Results From LRRK2 Inhibitor Program for Parkinson’s Disease
August 1, 2018 -
Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307
July 27, 2018 -
TraceLink Adds More than 130 New Customers in Q2 2018 with 255 Companies Now Live in Production, Exchanging Serialized Product Data on the Life Sciences Cloud
July 24, 2018 -
Centivo, a New Type of Health Plan, Raises $34 Million in Series A Funding
July 18, 2018 -
Consumers Demand Patient Data Protection as Black Book Names Protenus as Leading-Edge Innovator
July 17, 2018 -
Compass Therapeutics Closes on Series A Financing Totaling $132 Million
July 12, 2018 -
TraceLink Unveils Product Information Manager, a Standards-Based Network Application for Its Industry-Leading Digital Information Sharing Platform
July 10, 2018 -
US FDA Approves Adagene IO program IND for Solid Tumor and Non-Hodgkin Lympoma Ph1 trial
July 9, 2018 -
Tracelink partners with IBI Lorenzini, as FMD deadline looms over Europe
July 3, 2018 -
UMMC Selects Kyruus’ ProviderMatch for Access Centers to Improve Call Center Operations
July 2, 2018 -
Biotech Startup Innovent Files for Hong Kong Debut
July 2, 2018 -
Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors
June 29, 2018 -
BurstIQ Blockchain Healthcare Company Partners with VitalWare For Business Expansion
June 29, 2018 -
University of Mississippi Medical Center (UMMC) to Utilize Kyruus Technology to Enhance Patient Access and Patient-Provider Matching
June 28, 2018 -
WelbeHealth Raises $15 Million Series B to Accelerate Growth of Innovative Care Programs for Seniors
June 28, 2018 -
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
June 26, 2018 -
Italian Pharmaceutical Manufacturer and CMO, IBI Lorenzini, Selects TraceLink to Comply with Global Serialization Regulations
June 26, 2018 -
BurstIQ Announces Partnership with VitalWare(TM), Bringing Blockchain to Healthcare Revenue Cycle Management
June 26, 2018 -
Surface Oncology Recognized as one of the “Best Places to Work” by Boston Business Journal
June 21, 2018 -
VitalWare™ Introduces Advanced Charge Auditing Capabilities within Existing VitalAuditor™ Tool
June 21, 2018 -
Iora Health Looks to ‘Kick the Industry in the Behind’
June 19, 2018 -
Benchling Raises $14.5M From Benchmark to Advance Life Sciences Research
June 14, 2018 -
PatientPing Partners with WISHIN to Advance Care Coordination Throughout Wisconsin
June 13, 2018 -
Denali Therapeutics and AbCellera Announce Collaboration to Discover New Antibodies to Treat Neurodegenerative Diseases
June 12, 2018 -
TraceLink Tracks Down $60M to Fight Counterfeit Drugs Worldwide
June 11, 2018 -
Hua Medicine Planning Hong Kong IPO
June 6, 2018 -
TraceLink Customers Receive EMVO Approval for Data Submission to EU Hub
June 6, 2018 -
Adaptimmune Announces First Patient to Receive One Billion Target Cell Dose after Positive Safety Data from Pilot Study with MAGE-A4 SPEAR T-cells
June 4, 2018 -
Circulation Teams Up with AI Powered Buoy Health to Bring On-Demand Transportation Options to Millions of Patients Online
May 24, 2018 -
Navigant, Lumere Collaborate to Help Healthcare Providers Target Clinical and Financial Variation
May 23, 2018 -
Turnstone Biologics listed in top 10 among Canada’s 50 most attractive VC companies
May 22, 2018 -
Iora Health Raises $100 Million in Series E Financing
May 21, 2018 -
Protenus Recognized as One of the Best Places to Work in Healthcare in 2018
May 18, 2018
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.